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C-reactive protein point-of-care testing and antibiotic
prescribing for acute respiratory tract infections in rural primary
health centres of North Ethiopia: a cross-sectional study
Henock Yebyo1, Araya Abrha Medhanyie1, Mark Spigt2,3 and Rogier Hopstaken4
Unjustified antibiotic prescribing for acute upper respiratory infections (URTIs) is probably more common in poor-resource settings
where physicians are scarce. Introducing C-reactive protein (CRP) point-of-care testing in such settings could reduce the misuse of
antibiotics, which could avert antibiotic resistance. However, information useful for the applicability of CRP test in resource-limited
settings is lacking. This study aimed to elicit the frequency of antibiotic prescribing and distribution of CRP levels in remote,
rural settings in Ethiopia. We included 414 patients with acute URTIs from four health centres. Health professionals recorded the
clinical features of the patients, but the laboratory professionals measured the CRP levels of all patients at the point of care.
The most prominent respiratory causes for consultation were acute URTIs combined (44.4%), and lower respiratory tract
infections—pneumonia (29.71%) and acute bronchitis (25.84%). The CRP distribution was o20 mg/l, 20–99 mg/l and 100 mg/l
or more in 66.6%, 27.9% and 5.5% of the patients, respectively. The CRP levels were significantly different among these clinical
diagnoses (X2 = 114.3, Po0.001, d.f. = 4). A wide range of antibiotics was administered for 87.8% of the patients, regardless of
the diagnostic or prognostic nature of their diseases. Antibiotic prescribing for acute URTIs in the rural areas of Ethiopia is
unduly high, with high proportions of mild, self-limiting illness, mostly URTIs. Implementation of CRP point-of-care testing in such
resource-constrained settings, with low- or middle-grade healthcare professionals, could help reconcile the inappropriate use of
antibiotics by withholding from patients who do not benefit from antibiotic treatment.
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INTRODUCTION
Acute respiratory tract infections (RTIs), both upper (URTI) and
lower, are among the most common reasons to consult in primary
care and a frequent reason to prescribe antibiotics. Most of these
prescriptions are not helpful and only contribute to the emerging
problem of bacterial resistance.1–3
The use of tonnes of antibiotics over the past years has made
almost all disease-causing bacteria resistant to antibiotics
commonly used to treat them.4,5 Studies show that improper
use of antibiotics is more pronounced in acute respiratory
infections to which antibiotics do not meaningfully change
important outcomes.6,7 Diagnostic (viral or bacterial cause) or
prognostic (life-threatening or self-limiting infection) uncertainty
makes it difficult for clinicians to know when to prescribe and
when to withhold antibiotic treatment.5,6 Consequently, antibio-
tics are overused in hospitals and outpatient settings, resulting in
increased antibiotic resistance8 and the pandemic spread of
highly resistant bacterial clones.9 The effects of antibiotic
resistance on human health are probably highest in countries
with the lowest income, because the spread of resistant bacteria is
facilitated by poor hygiene, contaminated food, polluted water,
overcrowding and increased susceptibility to infection resulting
from malnutrition or HIV.3
Acute respiratory tract infections are the leading reason for
outpatient visits and prescription of antibiotics for both adults and
children in primary healthcare units (PHUs) in Ethiopia.10 Health
workers in primary healthcare settings in Ethiopia are not medical
doctors, but usually nurses, midwives or health officers.11
Additional investigations like laboratory testing and chest
radiography are neither accessible nor feasible.12 The urge for
simple, cheap and accurate tools that could help to create better
antibiotic stewardship is evident.1,13
C-reactive protein (CRP), an acute-phase reactant, is a diagnostic
marker that helps to differentiate serious infections like
pneumonia and sepsis from self-limiting illnesses.14–16 The effect
of CRP point-of-care testing (POCT) in reducing antibiotic
prescribing for lower respiratory tract infections has been
demonstrated in developed countries.1,2,17 Despite its potential,
however, CRP POCT is not widely used in resource-limited
countries.17 The nature and severity of diseases presented in
primary care in low-income countries could be very different from
developed countries. If, for example, people have to travel a long
way to a health centre, they may only visit the health centre with
very severe diseases. This could make the use of CRP testing less
relevant.6
Therefore, this study aimed to study the distribution of CRP
levels for acute URTIs and the frequency of antibiotic prescribing
to patients presented with these diseases in Primary Health Care
Units in rural Northern Ethiopia. The findings could help to decide
whether the CRP POCT could assist health professionals in
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diagnosis and antibiotic prescribing during consultation in
low-income countries.
RESULTS
Socio-demographic and medical description of the study patients
We included 414 adult patients with acute URTIs. The average age
of the patients was 40.3 years. The majority of them were illiterate
(239, 59.6%). Almost equivalent numbers of patients were
recruited from the four health centres (Table 1). Twelve health
professionals participated: six bachelor-degree-holding nurses,
four midwives and two health officers.
Medical presentations
All patients had at least one of the symptoms of acute URTIs. With
regard to the compulsory inclusion criteria, the most frequent
medical symptom was acute cough, which was presented in
83.2% of the patients and accounted for nearly one-third of all the
signs/symptoms (34.4%), whereas 8.4% of them had worsening
chronic cough. The rest, 8.4%, did not have clear symptoms in
terms of time of having cough, acute versus chronic.
The patients had at least one of the four major clinical features
—shortness of breath, wheezing, chest pain and auscultation
abnormalities. Out of the generalised symptoms, the most
frequent were headache and chest pain, which presented in 134
(46.4%) and 138 (33.2%) patients, respectively (Table 2).
Diagnoses and CRP distribution
The top clinical diagnoses recorded by the healthcare
professionals, independent of the CRP levels, were acute URTIs
combined (44.4%), followed by pneumonia (29.6%) and acute
bronchitis (25.8%).
Overall, the median CRP level was 11 mg/l (interquartile range:
8–29). An overall 66.6% of patients had test results less than
20 mg/l; 27.9% had between 20 and 99 mg/l, and 5.5% had
100 mg/l or more (Figure 1). The distribution of CRP over the
different diagnoses showed that the majority of patients had low
CRP levels. In particular, a low CRP value was observed among
patients with unspecified acute URTIs (Figure 1). Statistically, there
was a significant difference in the CRP measurements among the
major diagnoses—acute bronchitis, pneumonia and unspecified
acute URTIs (X2 = 114.3, Po0.001, d.f. = 4; Figure 1).
Along with the current medical presentations, 16% of the
patients reported at least one other (chronic) illness. The most
frequently reported illness was chronic bronchitis, in 25 (6.0%)
patients, followed by peptic ulcer disease (PUD), reported by
8 (1.9%) patients (Table 3).
Antibiotic prescribing
The health providers prescribed a wide range of antibiotics in
87.8% of the cases and other drugs such as vitamin C and
analgesics in 7.4% of the patients. They provided reassurance only
to 4.8% of the patients. Amoxicillin was prescribed in 52.16% of
patients, Doxycycline in 11.3%, Erythromycin in 6.2%, analgesics in
5.5%, Ciprofloxacin and Contrimoxazole each in 3.8%, and others
in 17.2% (Table 4). In addition, 232 (55.7%) patients were
administered additional drugs. The most frequently prescribed
drugs as an addition to the primary medications were analgesics
(69.8%), Diphenhydramine (5.3%), Dexamethasone and Neomycin
(4.80%) and Vitamin B complex (3.06%).
DISCUSSION
Main findings
On the basis of the usual care—i.e., without the use of CRP levels
for management decisions – the study found that irrational
antibiotic prescribing for acute URTs was very high in Ethiopia.
Almost all patients received antibiotics, despite low severity and
low CRP values. The CRP distribution was similar to what has been
observed in European primary care studies on lower respiratory
tract infections.
Strengths and limitations of this study
Strengths. Irrational use of antibiotics is assumed to be high in
low-resource countries, which demands immediate remedy to halt
expansion of antibiotic-resistant microbes. As such, we believe
that the study is the first of its kind in low-resource countries to
test the feasibility of CRT POCT. This would have high relevance for
implementation of the POCT in resource-limited settings to reduce
unnecessary antibiotic prescribing. In addition, the study focussed
on the high World Health Organization (WHO) priority to address
the problem of bacterial resistance and to find ways to compact it.
The study also followed a pragmatic approach that it did
not violate the routine services for the patients. The health
professionals were blind to the cutoff values of CRP POCT (as set in
other countries), and the test was done after health professionals
had finished their contacts with the patients to avoid unbiased
management.
Limitations. The study may have limitations in that it is basically a
feasibility study and it would not prove that CRP POCT helps for
better antibiotic stewardship. It needs a randomised controlled
study to test whether CRP POCT can safely reduce antibiotic
prescriptions for acute URTIs in order to contribute to the fight
against antibacterial resistance. Selection bias of recruited patients
cannot be excluded; that is, we included all patients who fulfilled
the inclusion criteria and were presented to the study health
centres during the study period. However, we believe that the
presence of the patients to the health facility is independent of
the types and severity of the presented illness; thus, this might not
violate the estimated CRP distribution and antibiotic prescribing.
Interpretation of findings in relation to previously published work
Although the patients from developing countries were hypothe-
sised to have high levels of CRP because of the prevalence of
infectious diseases, the current study found that the distribution
for LRTs is comparable to that in patients in the Netherlands,
Table 1. Socio-demographic characteristics of the study patients
Characteristics Category Frequency (%)
Sex (n= 411)a Male 198 (48.2)
Female 213 (51.8)






Age (n= 386)a Average 40.3 years
Educational level
(n= 399)a
No education 238 (59.6)
Primary (1–6) 94 (23.5)




College or above 10 (2.5)
Health facility (n= 414) Negash Health centre 105 (25.2)
Agulae Health centre 101 (24.5)
Hiwane Health centre 109 (26.2)
Adigudem Health centre 99 (24.0)
aThere were missing values.
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where 69%, 24% and 7% of patients had o20 gm/l, 20–99 gm/l
and 4100 gm/l, respectively.2
The frequent causes of consultation in the study areas were
acute URTIs followed by pneumonia and bronchitis. The majority
of the patients were administered antibiotics regardless of the
severity or aetiology of the diseases.
In addition to the high uncertainty nature of the clinical features
to identify patients with viral or bacterial respiratory infections and
poor or no investigative facilities, the limited training of health
professionals in the PHU of Ethiopia could explain the misuse of
antibiotics. As revealed in clinical trials in developed countries,
only severe respiratory tract infections warrant antibiotic
treatment.1,2 Clinical trials show that patients with lower CRP
levels (o20 mg/l) were prescribed fewer antibiotics than those
with higher CRP levels,1,2,18,19 assuring that all patients do not
need antibiotics and the CRP cutoff points helped the health
professionals to decrease the antibiotics prescribing. In the current
study, the range of CRP levels of the patients were comparable to
those in previous European studies, but antibiotic prescribing was
much higher and generally regarded as inappropriately high. This
indicates that unnecessary antibiotics prescribing could be safely
reduced if CRP point-of-care testing is implemented.
With respect to diagnoses, the distribution of CRP levels in the
current study was higher in the clinically diagnosed pneumonia
cases. The distribution of CRP levels among the respiratory
diagnoses is similar to studies conducted in developed countries,
which reported that pneumonia cases had higher levels of CRP
than the acute bronchitis cases and acute URTIs.13,18 Studies show
that CRP cutoff points have importance in indicating pneumonia
cases. This was found effective to decrease unnecessary antibiotic
prescribing.13 CRP point-of-care testing would therefore be helpful
in poor-resource countries for assisting in diagnosis and antibiotic
prescribing; it would have paramount advantage in assisting
especially middle-grade healthcare professionals.
Implications for future research, policy and practice
The study results indicate the presence of huge antibiotic
overprescribing for mostly mild illnesses. This implies a high
potential use of CRP POCT in primary healthcare units of resource-
limited settings to help direct antibiotic prescribing together with
better education and training of health workers and the public.
However, other factors including the health workers’ attitudes
towards diagnostic testing, patients’ attitude towards antibiotics
prescribing, approval by regulatory authorities, recommendation
Table 2. The distribution of medical presentations among the patients
Inclusion clinical features Symptoms and signsa n % out of all recorded symptoms and signs % of patients
Compulsory Acute cough 346 33.1 83.2
Worsening chronic cough 35 3.3 8.4
Acute cough/worsening chronic cough (unclear) 33 3.2 7.9
Secondary Chest pain 138 13.2 33.2
Difficulty of breathing 81 7.7 19.5
Abnormal auscultation 36 3.4 8.6
Wheezing 20 1.9 4.8
Generalised symptoms Perspiration 22 2.1 5.3
Headache 193 18.5 46.4
Fever 134 12.8 32.2
Myalgia 08 0.7
Total 1046 100 N/A
aA patient could have more than one medical presentation; thus, the total is not equal to the number of patients.
Figure 1. The respiratory diseases by CRP distributions and 95%
confidence interval of the patients in four health centres, Tigray,
North of Ethiopia.
Table 3. The proportion of reported comorbidity among the patients
Comorbidity Frequency (%)
Chronic bronchitis 25 (6.01)





Bronchial asthma 3 (0.72)
















Dexamethasone and Neomycin 4 (1.0)
Reassurance 20 (4.8)
Vitamin C 4 (0.9)
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by guidelines, and social, ethical, economical and political factors
could affect the uptake of the CRP point-of-care testing in such
settings and thus should be studied before its implementation.
The high antibiotic prescribing is clearly a flaw that
can contribute to antibiotic resistance. Furthermore, the effects
of antibiotic resistance on human health are probably highest in
countries with the lowest income, because the spread of resistant
bacteria is facilitated by poor hygiene, contaminated food,
polluted water, overcrowding and increased susceptibility result-
ing from malnutrition or Tuberculosis/Human Immunodeficiency
Virus.5 As such, other studies are required to investigate the
resistance level and sensitivity tests to the common antibiotics in
use in Ethiopia.
Basically, the study is a feasibility study. This may not prove the
effect of CRP POCT in helping health professionals prescribe
appropriate antibiotics and reduce antibiotics. Yet, the results
strongly suggest the need for randomised clinical trials on CRP
POCT and training with antibiotic prescribing as a primary
outcome measure.
Conclusions
Antibiotic prescribing for acute URTIs in the Primary Health
Care Units of Ethiopia is unduly high, with high proportions of
mild, self-limiting illness, mostly URTIs. Implementation of CRP
point-of-care testing in such resource-constrained settings with
low educational level of health professionals could help reconcile
the inappropriate use of antibiotics by withholding from patients
who do not benefit from antibiotic treatment. In this way, Ethiopia
could prevent the unnecessary use of scarce health resources and
contribute to the fight against antibacterial resistance.
MATERIALS AND METHODS
Study settings
The study was undertaken in the Primary Health Care Units of Tigray
region, Northern Ethiopia. Four rural health centres were included.
In Ethiopia, a health centre is structured to offer curative outpatient
treatment and preventive services to nearly 25,000 people. They are
equipped with some basic laboratory facilities and basic pharmacies.
Nurses, health officers and midwives are assigned to diagnose and treat
patients. The health officer programme is a Bachelor's degree that trains
students for 4 years on medical practice, including diagnosis, investigation,
treatment and disease prevention.
Study design
This is a cross-sectional registration study that describes clinical
characteristics, routine management and distribution of CRP point-of-
care test results of patients visiting primary healthcare centres with acute
URTIs in rural Ethiopia.
Study population and procedures
All adult patients who presented with clinical features of an acute
respiratory infection were considered for the study. The inclusion criteria
were categorised as compulsory, secondary and generalised clinical
features. Patients aged 18 years and over with a new (i.e., o21 days) or
worsening cough, combined with at least one of the following four
secondary clinical features, namely, shortness of breath, wheezing, chest
pain and auscultation abnormalities, and one of the generalised
symptoms, namely, fever, perspiration, headache and myalgia, were
eligible to enter the study. On the basis of the availability of CRP test
kits from Saltro Diagnostic Centre, we included 414 patients in our study.
We included an equal proportion of patients from each health centre.
The health workers responsible for diagnosing and treating patients in
the health centres were trained to identify eligible patients for the test and
request the CRP test. However, they were not given the CRP cutoff points
for indications for treatment to avoid unbiased investigation of usual care
(care that would have been given without the CRP test) and the test was
conducted after contact with the patients.
CRP was measured by the NycoCard CRP test (http://www.alere.
com/ww/en/product-details/nycocard-crp.html), a 2-min, quantitative
immunometric test with a measuring range of 8–200 mg/l, run on the
NycoCard Reader II instrument. Considering positive CRP concentrations to
be 410 mg/l, the test has good specificity of 83.3% and sensitivity of
94.4% when compared with our CRP-Lab.20 The instrument is easy to use,
portable, and operates on batteries or electricity. The test requires one
drop of blood from the finger. The laboratory technicians in each of the
health centres carried out the procedure after a laboratory expert trained
them on performing the procedure and on test precautions including
proper storage and errors in reading.
Analyses
We analysed the data using Stata 11 (Stata Corporation, College Station,
TX, USA). We explored the data for errors and assumption fulfilments. The
proportions of the CRP levels, patterns of acute URTIs and antibiotic
prescribing levels were analysed using descriptive statistics. We computed
the CRP levels using the cutoff points for clinical relevance, set in clinical
trials and used in the guidelines on acute cough of the Dutch College of
General Practitioners, and the United Kingdom National Institute for Health
and Care Excellence guideline Pneumonia: Diagnosis and management of
community- and hospital-acquired pneumonia in adults.21,22 The cutoff
points were o20 mg/l, 20–99 mg/l and 4100 mg/l. The statistical
significance of the difference of the CRP measurements among the
diagnoses was tested using the χ2-test at P-value less than 0.05.
Ethical consideration
Ethical approval was obtained from the College of Health Sciences of
Mekelle University, Ethiopia, with reference number ERC 034/2013. As the
literacy rate is low in the study area, we relied on verbal consent. After
explanation of the purpose, information required from them, and the
procedure of the test, including the need of a drop of blood from their
fingers, verbal consent was obtained from each patient. The patients were
informed about their right to withdraw from the study at any stage and
that no patient-identifying attributes would be encoded and reported in
any communication of the findings to keep their data confidential.
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